Saturday, 13 September 2008 19:29
Roxanne Nelson
Targeted therapies have significantly changed the treatment of cancer and are now considered to be a component of care for a number of common malignancies, including breast, colorectal, and lung cancers. In particular, they have significantly improved outcomes for patients with metastatic renal cell carcinoma (mRCC) and advanced gastrointestinal stromal tumors (GIST).
Last Updated ( Friday, 20 March 2009 21:06 )
Read more...
Sunday, 24 August 2008 18:51
Irakli Gagua
Facial transplantation can be a useful treatment for severe disfigurement, although it is not without risks, according to two case reports involving facial damage caused by a bear attack and by growth of a rare aggressive tumor. Both reports appear in the August 23rd issue of The Lancet.
Last Updated ( Friday, 20 March 2009 21:04 )
Read more...
Sunday, 24 August 2008 18:47
Irakli Gagua
Catheter-directed intervention can be life-saving for patients with massive pulmonary embolism (PE) who fail to respond to or cannot receive systemic thrombolysis, according to a report in the August issue of Chest.
Read more...
Sunday, 24 August 2008 18:40
Laurie Barclay, MD
Emergency medical services (EMS) providers may be less likely to transport elderly patients to a trauma center, according to the results of a retrospective analysis reported in the August issue of Archives of Surgery.
Read more...
Saturday, 23 August 2008 19:30
Irakli Gagua
Use of a chemofluorescence technique may allow surgeons to visualize, in real time, cancerous tissue, thereby increasing the precision of their resections, according to animal study findings presented Tuesday at the National Meeting of the American Chemical Society in Philadelphia.
Read more...
Saturday, 23 August 2008 19:23
Will Boggs, MD
Although most maternal deaths are not preventable, thromboembolism prophylaxis could reduce death rates in women undergoing cesarean delivery, according to a report in the July American Journal of Obstetrics & Gynecology.
Read more...
|
Tuesday, 19 August 2008 18:48
Irakli Gagua
In addition to confirming previously identified risk factors for cardiovascular complications after total joint replacement (TJR) surgery, researchers have shown that bilateral and revision operations are associated with increased risk.
"Revision joint replacement and bilateral surgery are much more prolonged operations than primary unilateral joint replacement," Dr. Jeffrey N. Katz, from Brigham and Women's Hospital in Boston, said in a statement. "These findings suggest an increased risk with more prolonged surgery."
Read more...
Tuesday, 19 August 2008 18:47
David Douglas
In patients undergoing liver resection for hepatocellular carcinoma related to hepatitis B virus (HBV) infection, viral load at the time of surgery is predictive of hepatoma recurrence, according to Chinese researchers.
Read more...
Tuesday, 19 August 2008 18:41
Scott Baltic
Elevated free plasma DNA is a reliable indicator of recurrent esophageal cancer, more so than carcinoembryonic antigen (CEA), and is able to detect recurrent disease in most patients before clinical evidence emerges. These findings come from a study by researchers at the University of Southern California, published in the July issue of the Journal of the American College of Surgeons.
Read more...
Tuesday, 19 August 2008 18:31
Karla Gale
Laparoscopic surgeons who play video games requiring spatial skills and dexterity are faster and less prone to error when performing advanced surgical procedures, researchers reported on Sunday at the Annual Convention of the American Psychological Association in Boston.
Read more...
Tuesday, 19 August 2008 18:25
Michael O'Riordan
A new review by three renowned experts in cardiology suggests that efforts to treat elevated cholesterol levels are not exploiting the full potential of cholesterol-lowering strategies, and current approaches to treatment are simply doing "too little, too late. [1]" The evidence, say these experts, is strong enough to support even more aggressive use of lipid-lowering therapies and to intervene at earlier stages in the development of atherosclerosis.
Read more...
Tuesday, 19 August 2008 18:19
Laurie Barclay, MD
Polyalkylimide implants (PAI) used as dermal fillers can infrequently result in delayed and recurrent chronic inflammatory and granulomatous reactions, according to the results of a study published in the May issue of the Archives of Dermatology.
Read more...
|